Table III.
The relative prevalence of PrEP use disclosure in the first 6 months of follow-up among those ≤ 18 years vs. > 18 years (N = 193)
| Disclosure prevalence | ||||
|---|---|---|---|---|
| ≤18 years | >18 years | PRa | 95% CI | |
|
|
||||
| Total, n | 86 | 107 | ||
| Disclosed to anyone, n (%) | 76 (88%) | 96 (90%) | 0.99 | 0.89, 1.09 |
| Disclosed to a parent, n (%) | 57 (66%) | 54 (50%) | 1.31 | 1.03, 1.67 |
| Disclosed to a partner, n (%) | 50 (58%) | 61 (57%) | 1.02 | 0.80, 1.30 |
| Disclosed to a sibling, n (%) | 49 (57%) | 64 (60%) | 0.95 | 0.75, 1.21 |
| Disclosed to other family, n (%) | 55 (64%) | 59 (55%) | 1.16 | 0.92, 1.46 |
| Disclosed to a friend, n (%) | 72 (84%) | 84 (79%) | 1.07 | 0.93, 1.22 |
| Disclosed to a neighbor, n (%) | 23 (27%) | 31 (29%) | 0.92 | 0.58, 1.46 |
| Disclosed to nurse/doctor n (%) | 10 (12%) | 7 (7%) | 1.78 | 0.71, 4.47 |
a
>18 years = referent group
PR=prevalence ratio; CI=confidence interval
PR and aPR estimates and 95% CIs were calculated using log-binomial regression
95% CI overlap with the null value of 1.0 was used to assess statistical significance of PR estimates